Cost-Effectiveness Analysis of the Multicenter Scale-Up of the SAFE@Home Telemonitoring Platform for Blood Pressure and Symptoms in Women with Hypertensive Disorders of Pregnancy
This CEA demonstrated that at scale, SAFE@home modestly reduces costs. With lower costs per adverse outcome resulting in a negative ICER, SAFE@home dominates CAU. Future research should explore how telemonitoring can optimize use of resources. In conclusion, addressing adoption barriers is essential to sustainably integrate telemonitoring.
Authors
- Chris van Lieshout (ORCID: https://orcid.org/0000-0002-2870-9439)
- Jacques Dirken
- Roel de Heus (ORCID: https://orcid.org/0000-0002-7170-7543)
- Shinta L. Moes (ORCID: https://orcid.org/0000-0002-1385-8773)
- A. Franx
- Steven V. Koenen
- Lindy Santegoets
- Ingelin Kvamme
- K. Ahaus
- Flip van der Made
- Sanne J. Gordijn
- Ewoud Schuit
- A. Titia Lely
- Mireille N. Bekker
- Elles In ‘T Anker
- Martine Depmann
- Marc Spaanderman
- Leonoor van Eerden
Institutions
- University Medical Center Groningen (NL)
- Utrecht University (NL)
- Erasmus MC (NL)
- University Medical Center Utrecht (NL)
- Maastricht University (NL)
- Reinier de Graaf Hospital (NL)
- St. Antonius Ziekenhuis (NL)
- Maasstad Ziekenhuis (NL)
- Jeroen Bosch Ziekenhuis (NL)
- Bravis Ziekenhuis (NL)
- Erasmus University Rotterdam (NL)
Publication Details
- Journal
- Telemedicine Journal and e-Health
- Published
- 2026-01-12
- DOI
- https://doi.org/10.1177/15305627251407897
- Primary Topic
- Pregnancy and preeclampsia studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00